2.0.0.0 ADVOCACY STATEMENTS
2.1.0.0 Introduction
Partial list, with the most recent publications appearing first
Insulin Access and Affordability Working Group: Conclusions and Recommendations (1)
(first publication 2018)
The ADA’s Insulin Access and Affordability Working Group compiled public information and convened a series of meetings with stakeholders throughout the insulin supply chain to learn how each entity affects the cost of insulin for the consumer. Their conclusions and recommendations are published in the ADA statement “Insulin Access and Affordability Working Group: Conclusions and Recommendations” (https://doi.org/10.2337/dci18-0019).